Inari Medical Q1 2024 GAAP EPS $(0.42) Misses $(0.16) Estimate, Sales $143.200M Beat $138.373M Estimate
Portfolio Pulse from Benzinga Newsdesk
Inari Medical (NASDAQ:NARI) reported Q1 2024 earnings with a GAAP EPS of $(0.42), missing the $(0.16) estimate, but sales of $143.200M exceeded the $138.373M forecast, marking a 23.27% increase from the previous year.
April 30, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Inari Medical reported a larger than expected quarterly loss but exceeded sales forecasts, indicating mixed financial health.
The missed EPS estimate by a significant margin could concern investors about profitability, potentially pressuring the stock. However, the beat on sales forecasts and a strong year-over-year sales growth might offset some of the negative sentiment, suggesting a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100